Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117754022 | 11775402 | 2 | F | 2000 | 20160823 | 20151125 | 20160907 | EXP | US-JNJFOC-20151105315 | JANSSEN | 0.00 | A | M | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117754022 | 11775402 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | 3 | MG | TABLETS | |||||||
117754022 | 11775402 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | 3 | MG | TABLETS | |||||||
117754022 | 11775402 | 3 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 1-6 MG, 3MG | U | 0 | TABLETS | ||||||||
117754022 | 11775402 | 4 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | TABLETS | |||||||||
117754022 | 11775402 | 5 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | 3 | MG | TABLETS | |||||||
117754022 | 11775402 | 6 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | TABLETS | |||||||||
117754022 | 11775402 | 7 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | 3 | MG | TABLETS | |||||||
117754022 | 11775402 | 8 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 1-6 MG, 3MG | U | 0 | TABLETS | ||||||||
117754022 | 11775402 | 9 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 1-6 MG, 3MG | U | 0 | TABLETS | ||||||||
117754022 | 11775402 | 10 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | TABLETS | |||||||||
117754022 | 11775402 | 11 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | 3 | MG | TABLETS | |||||||
117754022 | 11775402 | 12 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | 3 | MG | TABLETS | |||||||
117754022 | 11775402 | 13 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | 3 | MG | TABLETS | |||||||
117754022 | 11775402 | 14 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | 3 | MG | TABLETS | |||||||
117754022 | 11775402 | 15 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | TABLETS | |||||||||
117754022 | 11775402 | 16 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | 1-6 MG, 3MG | U | 20272 | TABLETS | ||||||||
117754022 | 11775402 | 17 | SS | RISPERDAL CONSTA | RISPERIDONE | 1 | Intramuscular | U | 0 | MICROSPHERES | |||||||||
117754022 | 11775402 | 18 | SS | RISPERDAL CONSTA | RISPERIDONE | 1 | Intramuscular | 25-50 MG | U | 21346 | MICROSPHERES | ||||||||
117754022 | 11775402 | 19 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | TABLETS |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
117754022 | 11775402 | 1 | Mental disorder |
117754022 | 11775402 | 2 | Mental disorder |
117754022 | 11775402 | 3 | Mental disorder |
117754022 | 11775402 | 4 | Mental disorder |
117754022 | 11775402 | 5 | Schizoaffective disorder depressive type |
117754022 | 11775402 | 6 | Schizoaffective disorder depressive type |
117754022 | 11775402 | 7 | Schizoaffective disorder depressive type |
117754022 | 11775402 | 8 | Schizoaffective disorder depressive type |
117754022 | 11775402 | 9 | Attention deficit/hyperactivity disorder |
117754022 | 11775402 | 10 | Attention deficit/hyperactivity disorder |
117754022 | 11775402 | 11 | Attention deficit/hyperactivity disorder |
117754022 | 11775402 | 12 | Attention deficit/hyperactivity disorder |
117754022 | 11775402 | 13 | Schizophrenia |
117754022 | 11775402 | 14 | Schizophrenia |
117754022 | 11775402 | 15 | Schizophrenia |
117754022 | 11775402 | 16 | Schizophrenia |
117754022 | 11775402 | 17 | Product used for unknown indication |
117754022 | 11775402 | 18 | Product used for unknown indication |
117754022 | 11775402 | 19 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
117754022 | 11775402 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
117754022 | 11775402 | Gynaecomastia | |
117754022 | 11775402 | Nephropathy | |
117754022 | 11775402 | Obesity | |
117754022 | 11775402 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
117754022 | 11775402 | 2 | 1999 | 2000 | 0 | |
117754022 | 11775402 | 3 | 1994 | 2014 | 0 | |
117754022 | 11775402 | 4 | 20140728 | 0 | ||
117754022 | 11775402 | 6 | 20140728 | 0 | ||
117754022 | 11775402 | 7 | 1999 | 2000 | 0 | |
117754022 | 11775402 | 8 | 1994 | 2014 | 0 | |
117754022 | 11775402 | 9 | 1994 | 2014 | 0 | |
117754022 | 11775402 | 10 | 20140728 | 0 | ||
117754022 | 11775402 | 12 | 1999 | 2000 | 0 | |
117754022 | 11775402 | 14 | 1999 | 2000 | 0 | |
117754022 | 11775402 | 15 | 20140728 | 0 | ||
117754022 | 11775402 | 16 | 1994 | 2014 | 0 | |
117754022 | 11775402 | 17 | 20140728 | 0 | ||
117754022 | 11775402 | 18 | 1994 | 2014 | 0 |